Malaria Prophylaxis with Doxycycline

Indications and Dosage

• The American College of Physicians recommends doxycycline 100 mg orally once daily for malaria prophylaxis, starting 1-2 days before travel to the malarious area, continuing daily throughout travel, and for 4 weeks after leaving the endemic region 1
• The Centers for Disease Control and Prevention indicate that doxycycline is a first-line option for chloroquine-resistant malaria areas, as an alternative to atovaquone-proguanil or mefloquine 1, 3
• The World Health Organization suggests doxycycline for mefloquine-resistant regions, particularly in East Asia, including Thailand, Myanmar, Cambodia, Laos, and Vietnam 4, 5, 3

Contraindications

• The British Medical Association advises against using doxycycline in pregnant women, due to the risk of inhibiting bone growth and causing tooth discoloration in the fetus 5, 1
• The American Academy of Pediatrics recommends avoiding doxycycline in children under 8 years of age, due to the risk of permanent tooth discoloration and impaired bone growth 1, 3

Side Effects and Precautions

• The British Medical Journal warns that doxycycline can cause severe and prolonged photosensitivity, and advises patients to avoid excessive sun exposure, use high-SPF sunscreen, and wear protective clothing 4, 5, 1
• The National Institute of Health notes that doxycycline can interact with phenytoin, carbamazepine, and barbiturates, potentially requiring dose increases 4, 5

Post-Exposure Management

• The Centers for Disease Control and Prevention recommend adding primaquine 30 mg base daily during the last 2 weeks of the 4-week post-exposure doxycycline prophylaxis period for travelers with prolonged exposure to P. vivax or P. ovale endemic areas 1
• The World Health Organization advises mandatory G6PD testing before primaquine use, as it is contraindicated in G6PD deficiency and pregnancy 1